-
2020/06/24
Clinical program for NY-ESO-1・siTCR(TM) gene therapy candidate receives designation in Japan as Orphan Regenerative Medicine
-
2020/03/06
Takara Bio to Support Development of Novel Coronavirus VaccineUndertaken by Osaka University Group
-
2020/01/21
Takara Bio Launches a New Facility for the Research and Manufacturing of Regenerative Medicine Products
-
2020/01/16
Takara Bio and Tmunity Enter into License Agreement to Advance siRNA Technology to Improve T cell Therapies
-
2019/09/24
Takara Bio to Present Clinical Data of Oncolytic Virus C-REV
and NY-ESO-1・siTCR Gene Therapy at ESMO 2019